On this episode of Soundbites of the Annual Meeting, we talked to Stephen Kaminsky, PhD, professor of research in genetic medicine at Weill Cornell Medical College, and lead author of a phase 1 clinical trial of a new vaccine for cocaine addiction.

In his conversation with ASGCT's Communications Committee Chair, Lynnea Olivarez, Dr. Kaminsky discusses:
How the vaccine works and how its approach is different from other treatments
Safety results from the unblinded data
Implications this vaccine could have for other substance use disorders

Listen and subscribe to the ASGCT Podcast Network so you don't miss any episodes!

On this episode of Soundbites of the Annual Meeting, we talked to Stephen Kaminsky, PhD, professor of research in genetic medicine at Weill Cornell Medical College, and lead author of a phase 1 clinical trial of a new vaccine for cocaine addiction.
In his conversation with ASGCT's Communications Committee Chair, Lynnea Olivarez, Dr. Kaminsky discusses:
<ul>
<li>How the vaccine works and how its approach is different from other treatments</li>
<li>Safety results from the unblinded data</li>
<li>Implications this vaccine could have for other substance use disorders</li>
</ul>
Listen and subscribe to the <a href="https://www.asgct.org/publications/asgct-podcast-network">ASGCT Podcast Network</a> so you don't miss any episodes!

The American Society of Gene & Cell Therapy is the premier membership organization for professionals working in cell and gene therapy. On this network, we're sharing exciting stories from our members and the greater scientific community.

The American Society of Gene &amp; Cell Therapy is the premier membership organization for professionals working in cell and gene therapy. On this network, we're sharing exciting stories from our members and the greater scientific community.

Advertisement